Precision Biosciences (DTIL) Research & Development (2018 - 2025)
Historic Research & Development for Precision Biosciences (DTIL) over the last 8 years, with Q3 2025 value amounting to $13.4 million.
- Precision Biosciences' Research & Development rose 204.83% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.6 million, marking a year-over-year decrease of 250.0%. This contributed to the annual value of $59.6 million for FY2024, which is 1158.59% up from last year.
- According to the latest figures from Q3 2025, Precision Biosciences' Research & Development is $13.4 million, which was up 204.83% from $12.8 million recorded in Q2 2025.
- In the past 5 years, Precision Biosciences' Research & Development registered a high of $37.2 million during Q2 2021, and its lowest value of $11.0 million during Q1 2023.
- Its 5-year average for Research & Development is $17.6 million, with a median of $13.6 million in 2025.
- Its Research & Development has fluctuated over the past 5 years, first soared by 4785.77% in 2021, then plummeted by 5467.23% in 2022.
- Quarter analysis of 5 years shows Precision Biosciences' Research & Development stood at $26.5 million in 2021, then tumbled by 52.09% to $12.7 million in 2022, then grew by 5.57% to $13.4 million in 2023, then grew by 18.81% to $15.9 million in 2024, then dropped by 16.06% to $13.4 million in 2025.
- Its Research & Development stands at $13.4 million for Q3 2025, versus $12.8 million for Q2 2025 and $13.6 million for Q1 2025.